Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Distributed multicast packet replication with centralized quality of service
Method for evaluating performance characteristics of dental curing lights
Computing device with improved user interface for applications
Feature management of a communication device
System and method for providing an extended platform for an operating system
Apparatus and method for efficient transmission of acknowledgements
Dynamic bar oriented user interface
  Randomly Featured Patents
Assessing petroleum reservoir production and potential for increasing production rate
Composition comprising at least one 1,8-dihydroxynaphthalene derivative and at least one basifying agent different from aqueous ammonia, process for dyeing keratin fibres using the composition
Crankshaft apparatus
Fire suppressor for electronic enclosures
Light emitting device driver circuit, light emitting device array controller and control method thereof
Treatment of glaucoma and ocular hypertension with .beta..sub.3 -adrenergic agonists
Non-bleeding thixotropic thermally conductive material
Decorative LED tail light arrangement
Polymeric products